EU backs Pfizer jab for 12 to 15-year- olds
The EU's drug watchdog has approved the Pfizer/BioNTech coronavirus jab for 12 to 15-year-olds, the first vaccine to get the green light for children in the bloc
Covid-19 vaccines online or in development
With several Covid-19 vaccines either being rolled out or under trial, here is a rundown of the various stages of their development
Questions surround AstraZeneca vaccine use for elderly
The subject of a sometimes acrimonious row between the EU and Britain, the AstraZeneca Covid-19 vaccine has also fuelled debate over its effectiveness among the elderly
BioNTech: Vaccine likely also effective against new variants
Even if the coronavirus has mutated, German vaccine manufacturer BioNTech still believes that it is highly likely it can be combatted effectively. Company boss Ugur Sahin is considering new production facilities for the vaccine so that orders can be delivered earlier.
How the world has sped up vaccine approvals
As Britain becomes the first Western country to approve a Covid-19 vaccine for general use, authorities in Europe, the US, Russia and China have also sped up their approval procedures
EU regulator defends vaccine rules as Britain OKs jab
The EU's medicines regulator insists it has the "most appropriate" method to approve a coronavirus vaccine, after Britain became the first Western country to give one the green light
Frontrunners emerge in race for Covid-19 vaccine
Positive results from trials of several vaccine candidates have raised hopes that there is light at the end of the tunnel in the quest to curb a pandemic that has already killed 1.4 million
Vaccine innovation sparks hope, questions
Pfizer and BioNTech say their vaccine is 90% effective in preventing Covid-19 infections, but experts say the announcement raises many questions such as who it will protect and for how long?
BioNTech: plucky German upstart leads Covid-19 vaccine race
German biotech firm BioNTech has never brought a vaccine to market before but it is now in pole position in the race to develop a jab that will end the coronavirus crisis